Volition公布肺癌风险分层研究摘要 亮相欧洲肺癌大会

美股速递
Mar 26

VolitionRX有限公司宣布,其关于肺癌风险分层的研究摘要已在欧洲肺癌大会上正式发布。

该项研究展示了利用新型生物标志物进行肺癌风险分层的潜力,为早期诊断和个性化治疗提供了重要依据。研究成果的发布标志着公司在肿瘤诊断领域取得又一重要进展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10